Marc Grasso

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

KYTX

Current role

CFO

KURA

CFO

7 calls Latest call 2021-11-04

ALEC

CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Kyverna Therapeutics, Inc. (KYTX)	Chief Financial Officer	$256,961	$100,000	—	$1,100,025	$204,000	$2,550	$1,663,536
2024	Alector, Inc. (ALEC)	Chief Financial Officer	$514,777	—	$984,620	—	$182,230	$6,242	$1,687,869
2023	Alector, Inc. (ALEC)	Chief Financial Officer	$496,800	—	$797,040	$190,092	$225,672	$6,242	$1,715,846
2022	Kura Oncology, Inc. (KURA)	Former Chief Financial Officer and Chief Business Officer	$45,608	—	$309,885	$1,274,353	—	$64,871	$1,694,717
2022	Alector, Inc. (ALEC)	Chief Financial Officer	$432,923	$103,000	$337,741	$4,935,992	$200,448	$1,676	$6,011,780
2021	Kura Oncology, Inc. (KURA)	Former Chief Financial Officer and Chief Business Officer	$446,300	$38,493	—	$3,704,925	$126,638	$40,252	$4,356,608
2020	Kura Oncology, Inc. (KURA)	Former Chief Financial Officer and Chief Business Officer	$415,000	—	—	$873,160	$257,300	$43,648	$1,589,108
2019	Kura Oncology, Inc. (KURA)	Former Chief Financial Officer and Chief Business Officer	$387,750	—	—	$1,481,424	$152,929	$90,179	$2,112,282
2018	Kura Oncology, Inc. (KURA)	M.D.^(^^4)^ Chief Financial Officer and Chief Business Officer	$136,876	$100,000	—	$3,288,000	$69,426	$39,965	$3,634,267

Earnings-call appearances and filed executive appointments or departures, newest first.